Co-Diagnostics, Inc. — Director's Dealing 2021

Jan 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2021-01-14

Reporting Person: SERBIN RICHARD S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-14	Common Stock	S	10000	$10.29	Disposed	2500	Direct

Footnotes

F1: Reflects shares acquired upon vesting of restricted stock unit ("RSU").

F2: This transaction was executed in multiple trades at sales prices ranging from $10.28 to $10.35 per share. The price reported in Column 4 reflects the weighted average sale price of the shares sold. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the multiple sales of the transaction were effected.